Invention Grant
US09381235B2 Programming of cells for tolerogenic therapies 有权
用于耐受性治疗的细胞编程

Programming of cells for tolerogenic therapies
Abstract:
Biomaterial systems, e.g., gel scaffolds, are used in vivo to recruit immune cells and promote their activation towards a non-inflammatory phenotype, thereby leading suppression of inflammation. The compositions and methods are useful to reduce the severity of autoimmunity, chronic inflammation, allergy, and periodontal disease.
Public/Granted literature
Information query
Patent Agency Ranking
0/0